Second Photo
fundable.
DATA PLATFORM
  • Dashboard
  • Companies
  • People
  • Investment Firms
  • Angels & Partners
COLLECTIONS
  • Lists
  • Saved Searches
  • Hiring Lists
WORKFLOWS
  • Deal Alerts
  • Integrations
  • API


logo
Odyssey Therapeutics logo

Odyssey Therapeutics

Recent Finacing

Series D

Recent Raise

$213M

Odyssey Therapeutics is a clinical-stage biopharmaceutical company developing precision immunomodulators and oncology medicines using an integrated discovery platform combining AI/ML, structural and medicinal chemistry, covalent libraries, and functional genomics.

Founded 2021
Massachusetts, United States
51-100
Private
odysseytx.com
PitchBook

Highlights

Focus Areas

Biotechnology
Health Care
Oncology
Therapeutics

Recent Investors

SR One logo
C
Woodline Partners logo
Colt Ventures logo
OrbiMed logo
HBM Healthcare Investments logo
Foresite Capital logo
Logos Capital logo
Alexandria Venture Investments logo
T. Rowe Price Associates logo
Walleye Capital logo
General Catalyst logo

Financials

$700M

Total Raised

4

Funding rounds

30

Investors


Team

Upgrade to view the team

See the team members at Odyssey Therapeutics.